• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Concentra Group Holdings Parent Inc.

    11/27/24 4:01:21 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    SC 13G/A 1 tm2429618d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2

    (Amendment No. 1)*

     

    Concentra Group Holdings Parent, Inc.
    (Name of Issuer)
     
    Common Stock, par value $0.01 per share
    (Title of Class of Securities)
     
    20603L102
    (CUSIP Number)
     
    November 25, 2024
    (Date of Event Which Requires Filing of this Statement)
     
                          Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    x Rule 13d-1(d)

     

     

    *     The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior coverage page.

     

          The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 81619Q105        

     

    1.

    NAMES OF REPORTING PERSONS

     

    Select Medical Corporation

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a)     ¨
    (b)     ¨
    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER   -0-
    6. SHARED VOTING POWER -0-
    7. SOLE DISPOSITIVE POWER   -0-
    8. SHARED DISPOSITIVE POWER -0-

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    -0-

     

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    -0-

     

    12.

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     

     

    AMENDMENT NO. 1 TO SCHEDULE 13G (FINAL AMENDMENT)

     

    Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on September 5, 2024 (the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.

     

    The following Items of the Schedule 13G are hereby amended and restated to read in their entirety as follows:

     

    Item 4. Ownership.

     

    (a) through (c):

     

    The information requested in these paragraphs is incorporated by reference to the cover page to this Amendment No. 1 to Schedule 13G.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that the Reporting Person has ceased to be the beneficial owner of more than five percent of the Common Stock, check the following: x

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 27, 2024

     

      SELECT MEDICAL CORPORATION  
       
      By: /s/ Michael E. Tarvin
      Name: Michael E. Tarvin  
      Title: Senior Executive Vice President, General Counsel & Secretary

     

     

     

    Get the next $CON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    7/1/2026Outperform
    William Blair
    6/5/2026$30.00Buy
    Goldman
    9/18/2025$31.00Overweight
    Analyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    More analyst ratings

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Expands into Idaho with Opening of Boise Medical Center

    Investment in Boise reflects Idaho’s continued growth and increasing demand for workforce health services Concentra® (NYSE:CON), the nation's leader in occupational and workforce health services, today announced the opening of its first Idaho medical center, expanding access to workforce health solutions for employers and employees throughout the Boise region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717723429/en/Concentra's new Boise medical center will officially open with a ribbon-cutting ceremony on July 22, expanding access to occupational health services for employers and employees across the Treasure Valley. Th

    7/20/26 10:30:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Expands Near Kansas City International Airport with New Medical Center

    New medical center near Kansas City International Airport strengthens workforce health resources for the region’s growing business and transportation hub Concentra (NYSE:CON), the nation's largest provider of occupational health services, today announced the opening of a new medical center in Kansas City, Missouri, further expanding access to specialized workforce health services in one of the Midwest's most dynamic business and transportation hubs. Located at 10304 NW Prairie View Road, Kansas City, Missouri 64153, Concentra Kansas City Airport will provide a comprehensive suite of occupational health services designed to help employers maintain healthy, productive workforces while sup

    7/13/26 9:00:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/9/26 4:00:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    SEC Filings

    View All

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    7/10/26 4:53:08 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 144 filed by Concentra Group Holdings Parent Inc.

    144 - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    7/1/26 4:45:24 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 144 filed by Concentra Group Holdings Parent Inc.

    144 - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    6/30/26 4:19:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ortenzio Robert A sold $3,964,597 worth of shares (130,000 units at $30.50) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    7/6/26 4:05:50 PM ET
    $CON
    Medical Specialities
    Health Care

    Director Ortenzio Robert A sold $3,250,026 worth of shares (130,000 units at $25.00) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    6/2/26 4:29:52 PM ET
    $CON
    Medical Specialities
    Health Care

    Director Ortenzio Robert A sold $3,250,000 worth of shares (130,000 units at $25.00) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    5/11/26 5:01:25 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Concentra

    William Blair initiated coverage of Concentra with a rating of Outperform

    7/1/26 8:29:15 AM ET
    $CON
    Medical Specialities
    Health Care

    Goldman initiated coverage on Concentra with a new price target

    Goldman initiated coverage of Concentra with a rating of Buy and set a new price target of $30.00

    6/5/26 8:26:54 AM ET
    $CON
    Medical Specialities
    Health Care

    Analyst resumed coverage on Concentra with a new price target

    Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00

    9/18/25 8:38:55 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Financials

    Live finance-specific insights

    View All

    Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/9/26 4:00:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today announced results for its first quarter ended March 31, 2026, the declaration of a cash dividend, and raised guidance for full year 2026. "Our strong start to 2026 is a testament to the trust our clients place in us to care for their most valuable asset: their people," said Keith Newton, Chief Executive Officer of Concentra. "The meaningful growth in visit volumes we saw this quarter demonstrates that our clinical model and value proposition continue to lead in workers' compensation. Building on our

    5/7/26 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra to Announce First Quarter 2026 Results on Thursday, May 7, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, May 8, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free: 888-5

    4/9/26 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care